CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Eyegene Inc Company Snapshot
Eyegene Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eyegene Inc with three other pharmaceutical manufacturers in Asia: Pharmaids Pharmaceuticals Limited of India (2017 sales of 12.03 million Indian Rupees [US$176,771.29 ] ), Patidar Buildcon Ltd of India (10.01 million Indian Rupees [US$147,212.11 ] ), and Zenotech Laboratories Limited which is also based in India (22.54 million Indian Rupees [US$331,367.40 ] ).

Sales Analysis. Eyegene Inc reported sales of 301.03 million Korean Won (US$279.66 thousand) for the year ending December of 2017. This represents an increase of 12.6% versus 2016, when the company's sales were 267.23 million Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Eyegene Inc
  Stock Performance Chart for Eyegene Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 27,000
(Figures in Korean Won)
1 Week -7.5%   13 Weeks -12.1%  
4 Weeks 29.2%   52 Weeks 194.8%  
 
Eyegene Inc Key Data:
  Ticker: 185490 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 301,033,820
(Year Ending Jan 2018).
Employees: 55
  Currency: Korean Won Market Cap: 296,091,234,000
  Fiscal Yr Ends: December Shares Outstanding: 10,966,342
  Share Type: Common Closely Held Shares: 2,240,207
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.